Pacific Health Care Organization, Inc. Reports its Second Quarter 2026 Financial Results

Net income halved despite flat revenues; cash flow sharply down from last year.

Risk flags

• ●Profitability risk is high, as net income fell by nearly half year-over-year despite stable revenues. This suggests rising costs or margin compression, which could persist if not addressed.
• ●Cash flow risk is evident, with net cash from operating activities dropping 72% compared to the prior year. Sustained cash flow deterioration could constrain future operations or require external financing.
• ●Disclosure risk exists because the announcement provides no breakdown of cost drivers, segment performance, or management commentary on the reasons for declining profitability. This lack of detail makes it difficult for investors to assess whether the issues are structural or temporary.

Bottom line

This quarterly update from Pacific Health Care Organization, Inc. shows flat revenues but a sharp drop in both net income and operating cash flow. The company offers no explanation for the profit decline or details on what drove higher costs or lower margins. No guidance, strategy, or operational context is provided, leaving investors with only the headline numbers and no insight into future prospects. The lack of forward-looking statements or management discussion limits the ability to assess whether these results are an anomaly or the start of a negative trend. Unless future disclosures address the drivers of margin and cash flow deterioration, the most important takeaway is that profitability and cash generation are under pressure despite stable top-line performance.

Announcement summary

(OTCQB: PFHO) Pacific Health Care Organization, Inc. filed its quarterly report on Form 10-Q announcing financial results for the quarter ended June 30, 2026. The Company reported total revenues of $1,774,651 for the quarter ended June 30, 2026, compared to $1,726,541 for the quarter ended June 30, 2025. Income from operations was $369,396 for the quarter ended June 30, 2026, compared to $303,559 for the quarter ended June 30, 2025. Net income was $327,008 or $0.03 per weighted average share outstanding, basic and diluted, for the quarter ended June 30, 2026, compared to $636,907 or $0.05 per weighted average share outstanding, basic and diluted, for the quarter ended June 30, 2025. Net cash provided by operating activities was $222,793 in the six months ended June 30, 2026, and $785,838 in the six months ended June 30, 2025. Net cash used in investing activities was $151,937 during the six months ended June 30, 2026, and $664,536 during the six months ended June 30, 2025. The Company’s balance of cash and cash equivalents at June 30, 2026 and December 31, 2025 was $2,239,664 and $2,168,808, respectively.

Disagree with this article?